Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Nabriva Therapeutics plc Ireland

Recent news which mentions Nabriva Therapeutics plc Ireland

Nabriva stock up after firm's antibiotic shows promise as a potential cystic fibrosis treatment
Tags Pharmaceuticals Insurance Nabriva Therapeutics plc Ireland
From Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
Tickers INNO
Tags Nabriva Therapeutics plc Ireland Stephen Willard Adaptimmune Therapeutics plc
From Business Journals
Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing
Tickers INNO
Tags Rajwanth Veluswamy Nabriva Therapeutics plc Ireland M/ Alexander Shaw
From Business Journals
Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale
Tickers INNO
Tags Nabriva Therapeutics plc Ireland Yuyang Cui Adaptimmune Therapeutics plc
From Business Journals
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
Tickers INNO
Tags Jeffrey F/ O'Donnell Jr/ Incyte Corp/ Biotech
From Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
Tickers INNO
Tags Biotech Endo International plc Drew Robinson
From Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
Tickers INNO
Tags Roundup Chris Garabedian Ben Franklin Technology Partners
From Business Journals
Lab Notes: Imvax presents new data on lead drug candidate; Neuronetics forms new partnership
Tickers INNO
Tags Biotech John P/ Furey Cabaletta Bio, Inc/
From Business Journals
Lab notes: Onconova completes $21M stock sale; Waypoint gets $1.7M investment
Tickers INNO
Tags Roberto Cuca Christine Guico/Pabia Nabriva Therapeutics plc Ireland
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.